Skip to main content
INNOVA CAPTAB LIMITED logo

INNOVA CAPTAB LIMITED — Investor Relations & Filings

Ticker · INNOVACAP ISIN · INE0DUT01020 LEI · 549300SNL5HFUHE66804 BSE.NS Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2024-02-14 Delisting Announcement
Country IN India
Listing BSE.NS INNOVACAP

About INNOVA CAPTAB LIMITED

https://www.innovacaptab.com

Innova Captab Limited is an integrated pharmaceutical company focused on the research, development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company operates primarily as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services to leading domestic and international pharmaceutical brands. Its product portfolio includes diverse dosage forms such as tablets, capsules, dry syrups, ointments, and injections across multiple therapeutic areas, including anti-infectives, analgesics, and gastrointestinal treatments. Innova Captab maintains a strong emphasis on R&D and quality control, operating advanced manufacturing facilities that adhere to global regulatory standards. In addition to its CDMO business, the company manages a domestic branded generics division and an international export business, catering to a global clientele with a focus on high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Updates
Delisting Announcement Classification · 100% confidence The document is a formal letter from Innova Captab Limited addressed to stock exchanges (BSE and NSE) informing about the delisting of its material subsidiary, Sharon Bio-Medicine Limited. It references regulatory provisions under SEBI Listing Regulations and includes official circulars from NSE and BSE confirming the delisting effective February 20, 2024. The content is an official notice about the removal of the company's stock from trading on these exchanges, which matches the definition of a Delisting Announcement. The document length is short (3126 characters) and contains no financial statements or detailed reports, confirming it is an announcement rather than a report. Therefore, the correct classification is Delisting Announcement (DLST).
2024-02-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to stock exchanges (BSE and NSE) regarding the availability of an audio recording of the earnings call for the quarter and nine months ended December 31, 2023 (Q3). It references the unaudited financial results for Q3 but does not contain the financial results itself, only a link to the audio recording. The document length is short (1800 characters), and it serves as a notification about the earnings call audio, not the transcript or the earnings release itself. Therefore, it is best classified as a Regulatory Filing (RNS) because it is an official regulatory announcement about the earnings call audio availability, not the earnings release or call transcript itself.
2024-02-14 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing them about the publication of a newspaper advertisement containing the extract of the company's un-audited financial results for the quarter and nine months ended December 31, 2023. The letter references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure requirements including publication of financial results. The document itself does not contain the financial results or detailed financial data but is a notification about the advertisement publication. The document length is short (2284 characters), and it states that the advertisement is enclosed or published, indicating it is an announcement rather than the report itself. Therefore, according to the MENU VS MEAL RULE, this document should be classified as a Regulatory Filing (RNS) rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2024-02-14 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is an Investor Presentation dated February 13, 2024, for the quarter and nine months ended December 31, 2023. It includes detailed financial highlights, MD's commentary, quarterly and nine months consolidated profit and loss statements, corporate snapshot, and key strengths. The document explicitly states it is an 'Investor Presentation' and is intended for an earnings call with analysts and investors. It contains substantive financial data and analysis for Q3 and 9M FY24, including revenue, EBITDA, PAT, margins, and segment information. It is not a brief announcement or a certification but a detailed presentation of financial results and company strategy. Therefore, the correct classification is Investor Presentation (IP).
2024-02-13 English
Financial Result Updates
Regulatory Filings
2024-02-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is an intimation to stock exchanges about the schedule of an analyst/institutional investor meeting and includes an earnings call invite for the 3QFY24 earnings conference call. It does not contain any financial statements or detailed financial data itself, but rather announces the upcoming earnings call event. The document is about scheduling and inviting participants to a conference call, which is typical for a Call Transcript (CT) precursor or an earnings call invite. Since it is not the transcript itself but an announcement of the call, it fits best under Call Transcript (CT) category as it relates directly to the earnings call event. The document length is about 4930 characters, which is consistent with an announcement or invite rather than a full report. Therefore, the classification is Call Transcript (CT) with high confidence.
2024-02-06 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.